GKB Ophthalmics — 360° view

GKB Ophthalmics, a company in the Medical Equipment & Supplies industry, reported revenue of ₹33 crore and net profit of ₹1.22 crore for the September 2026 quarter.

GKB Ophthalmics (NSE: GKB) closed at ₹57.00 on 20 Nov 2026. Its market capitalisation is ₹29 crore and it trades at 10.5 times earnings.

Share price
₹57.00 (20 Nov 2026)
Market cap
₹29 Cr (20 Nov 2026)
P/E
10.53 (20 Nov 2026)
Revenue
₹33 Cr (September 2026 quarter)
Net profit
₹1 Cr (September 2026 quarter)
ROCE
10.9% (FY26)
ROE
3.28% (FY26)
Book value
₹109 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹76.02 / ₹55.01 (20 Nov 2026)
Sector
Healthcare
Industry
Medical Equipment & Supplies
Symbol
NSE: GKB

Incorporated in 1981, GKB Ophthalmics Ltd is engaged in the manufacture and sale of ophthalmic lenses made up of Glass and Plastic.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.